Twitter LinkedIn
    Wednesday, March 22
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Fundraising»AXA IM Alts raises EUR1.9bn for European Life Sciences investments
    Fundraising

    AXA IM Alts raises EUR1.9bn for European Life Sciences investments

    July 26, 20212 Mins Read
    LinkedIn Facebook Twitter Email WhatsApp
    The Axa SA company logo sits outside the offices of Axa U.K., in London, U.K., on Monday, June 14, 2010. Axa SA, EuropeÕs second-biggest insurer, said itÕs in talks to sell part of its U.K. life insurance unit to Clive CowderyÕs Resolution Ltd. for 2.75 billion pounds ($4 billion). Photographer: Jason Alden/Bloomberg
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    AXA IM Alts has raised EUR1.9 billion of equity to accelerate investments into the Life Sciences sector.

    The capital was raised over the last seven months, with commitments to a significantly oversubscribed fund raise from a range of clients from North America, Asia and Europe. AXA IM Alts’ investments into the life science sector on behalf of clients are managed by its Real Assets platform, the leading real estate portfolio and asset manager in Europe.

    Already well established in the US, Life Sciences is an emerging but high potential asset class in Europe which is supported by a number of economic, demographic and technological changes, notably as it relates to healthcare. The sector is benefitting from a significant growth in available public and private funding. Companies in the sector are not just demanding additional space to accommodate their growth but are fundamentally considering how they organise themselves and recognising the value of being part of a relevant ecosystem.

    The capital raised will primarily be invested through Kadans Science Partner which AXA IM Alts completed the acquisition of in December last year. It will enable Kadans to execute new acquisition opportunities and continue to build out its existing development opportunities with a view to consolidating its market leading position in Europe.

    Read more/Source: Private Equity Wire

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Fundraising Investments PE Insider Private Equity
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Euroclear moves into $9.8 trillion private asset market with Goji buy

    December 21, 2022

    CAI raises over $1B for inaugural fund and co-investment programme

    November 18, 2022

    KKR looking to sell Canadian gas producer Westbrick for $1.13B

    November 18, 2022

    Carlyle targeting $1.6B for second renewables fund

    November 18, 2022

    Comments are closed.

    Other Articles

    Foresight Just Announced First Closing Of Its Latest Regional Private Equity Fund

    May 26, 2021

    Dubin Clark’s AWHAP acquires Temperature Control

    June 19, 2021

    KKR boosts renewable power presence with $2.2 billion deal for ContourGlobal

    May 17, 2022

    Golden State Warriors valued at US$5.5 billion as Arctos buys minority stake

    April 8, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?